6/26/2017 9:01:44 AM
REDMOND, Wash.–(BUSINESS WIRE)–Jun. 26, 2017–
Inc. (NASDAQ: MVIS), a leader in innovative ultra-miniature
projection display and sensing technology, today announced it has been
added as a member of the broad-market Russell 3000® Index,
effective after the US market opens on June 26, as part of the 2017
Russell indexes reconstitution.
Annual reconstitution of the Russell indexes captures the 4,000 largest
US stocks as of May 12th, ranking them by total market
capitalization. Membership in the Russell 3000® Index, which
remains in place for one year, means automatic inclusion in the
large-cap Russell 1000® Index or small-cap Russell 2000®
Index as well as the appropriate growth and value style indexes. FTSE
Russell determines membership for its Russell indexes primarily by
objective, market-capitalization rankings and style attributes.
“We are extremely pleased that MicroVision has been added to the Russell
3000 Index,” said Alexander Tokman, President and CEO of MicroVision.
“This inclusion is a nice acknowledgement of the progress we have made
in the past several years with our growth strategy, and we look forward
to continuing on this path.”
Russell indexes are widely used by investment managers and institutional
investors for index funds and as benchmarks for active investment
strategies. Approximately $8.4 trillion in assets are benchmarked
against Russell’s US indexes. Russell indexes are part of FTSE Russell,
a leading global index provider.
For more information on the Russell 3000® Index and the
Russell indexes reconstitution, go to the “Russell Reconstitution”
section on the FTSE
MicroVision is the creator of PicoP® scanning technology, an
ultra-miniature laser projection and sensing solution based on the laser
beam scanning methodology pioneered by the company. MicroVision’s
platform approach for this advanced display and sensing solution means
that it can be adapted to a wide array of applications and form factors.
It is an advanced solution for a rapidly evolving, always-on world.
MicroVision’s business model and product line offering includes display
and sensing engines, licensing its patented technology and selling
components to licensees for incorporation into their scanning engines.
Extensive research has led MicroVision to become an independently
recognized leader in the development of intellectual property.
MicroVision’s IP portfolio has been recognized by the Patent Board as a
top 50 IP portfolio among global industrial companies and has been
included in the Ocean Tomo 300 Patent Index. The company is based in
MicroVision and PicoP are trademarks of MicroVision, Inc. in the
United States and other countries. All other trademarks are the
properties of their respective owners.
About FTSE Russell:
FTSE Russell is a leading global index provider creating and managing a
wide range of indexes, data and analytic solutions to meet client needs
across asset classes, style and strategies. Covering 98% of the
investable market, FTSE Russell indexes offer a true picture of global
markets, combined with the specialist knowledge gained from developing
local benchmarks around the world.
FTSE Russell index expertise and products are used extensively by
institutional and retail investors globally. Approximately $12.5
trillion is currently benchmarked to FTSE Russell indexes. For over 30
years, leading asset owners, asset managers, ETF providers and
investment banks have chosen FTSE Russell indexes to benchmark their
investment performance and create investment funds, ETFs, structured
products and index-based derivatives. FTSE Russell indexes also provide
clients with tools for asset allocation, investment strategy analysis
and risk management.
A core set of universal principles guides FTSE Russell index design and
management: a transparent rules-based methodology is informed by
independent committees of leading market participants. FTSE Russell is
focused on index innovation and customer partnership applying the
highest industry standards and embracing the IOSCO Principles. FTSE
Russell is wholly owned by London Stock Exchange Group.
For more information, visit www.ftserussell.com.
Certain statements contained in this release, including those relating
to growth strategy, future product and product applications are
forward-looking statements that involve a number of risks and
uncertainties. Factors that could cause actual results to differ
materially from those projected in the company’s forward-looking
statements include the following: our ability to raise additional
capital when needed; products incorporating our PicoP® scanning
technology may not achieve market acceptance, commercial partners may
not perform under agreements as anticipated, we may be unsuccessful in
identifying parties interested in paying any amounts or amounts we deem
desirable for the purchase or license of IP assets, our or our customers
failure to perform under open purchase orders; our financial and
technical resources relative to those of our competitors; our ability to
keep up with rapid technological change; government regulation of our
technologies; our ability to enforce our intellectual property rights
and protect our proprietary technologies; the ability to obtain
additional contract awards; the timing of commercial product launches
and delays in product development; the ability to achieve key technical
milestones in key products; dependence on third parties to develop,
manufacture, sell and market our products; potential product liability
claims; and other risk factors identified from time to time in the
company’s SEC reports, including the company’s Annual Report on Form
10-K filed with the SEC. Except as expressly required by federal
securities laws, we undertake no obligation to publicly update or revise
any forward-looking statements, whether as a result of new information,
future events, changes in circumstances or any other reason.
Source: MicroVision, Inc.